Global Peripheral Vascular Devices Market - Growth, Trends & Forecasts 2017 - 2022

  • ID: 4387384
  • Report
  • Region: Global
  • 208 pages
  • Mordor Intelligence
1 of 4
The Global peripheral vascular device market has been estimated at USD XX billion in 2015 and is projected to reach USD XX billion by 2020, at a CAGR of XX% during the forecast period from 2015 to 2021. Peripheral Vascular devices are used in the treatment of blood vessels outside of the brain and heart. The common peripheral vascular disease includes the plaque buildups which causes insufficient blood flow due to the narrowing of the arteries.

The number of patients who have peripheral artery occlusive disease is steadily increasing worldwide and thus the peripheral vascular device market is project to grow.

The global peripheral vascular device market is going to be driven by the rising demand for minimally invasive procedures, upsurge of peripheral vascular diseases, change in lifestyle and aging population and the technological advancement in the development of new devices. However, the market is restrained by stringent regulatory framework, reimbursement issues in many developing countries and the highly fragmented market.

The global peripheral vascular device market is segmented based on the product types into angioplasty balloons, stents, embolic protection devices, inferior vena cava filters, aortic stent grafts, synthetic surgical grafts, peripheral vascular accessory devices, PTA balloon catheters, vascular closure devices and chronic total occlusion (CTO) devices. The angioplasty balloon is further segmented based on products (normal, cutting, scoring and drug coated) and on the material used (non compliant and semi compliant types). Based on stents the market is further segmented as balloon expandable stent, self expandable stents and covered stents.

Based on geographical location, the peripheral vascular device market can be divided into North America (USA, Canada and Mexico), Europe (France, UK, Germany, Spain, Scandinavia, Portugal, BENELUX, and Italy), Asia-Pacific (India, China, Japan, South Korea, Australia, and New Zealand), Middle East and Africa (GCC, Egypt) and Latin America (Brazil, and Argentina).

The growing use of bio-absorbable stents and the rise in health awareness and increasing expendable earnings are some market opportunities for the vendors. However, the cost of the procedure especially in developing countries and product failures which have been reported for many small players are some key challenges. The key market players in the global scenario are Abbot Laboratories, Angioscore, Boston Scientific Corporation, Bayer AG, Emboline INC among many others.

Key Deliverables:

Market analysis for the global peripheral vascular device market, with region specific assessments and competition analysis.
Market definition along with the identification of key drivers and restraints.
Identification of factors instrumental in changing the market scenarios, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale
Extensively researched competitive landscape section with profiles of major companies along with their market shares
Identification and analysis of the macro and micro factors that affect the Global vascular device market.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information
A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market
Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
Note: Product cover images may vary from those shown
2 of 4
1. Introduction
1.1 Report Description
1.2 Research Methodology
2. Key Findings
3. Executive Summary
4. Market Dynamics
4.1 Market Segmentation
4.2 Market Drivers
4.2.1 Rising demands to reduce healthcare costs
4.2.2 Patient Protection and Affordable Care ACT (ACA) encouraging hospitals to take up PHM programs
4.2.3 Emergence of Big Data Analytics boosting the growth of the market
4.2.4 Rise in demand for better patient quality of life
4.2.5 Increasing incidences of chronic disease population boosting the growth of the market
4.3 Market Restraints
4.3.1 Data privacy concerns
4.3.2 Lack of trained analysts hindering the market growth
4.3.3 Proper system needs to be framed for the smooth functioning of the PHM program which requires investment
5. Global Market Segmentation
5.1 By Component
5.1.1 Hardware
5.1.2 Software
5.1.3 Services Consulting Sustainability Model Analytics Business Intelligence Others
5.2 By Application
5.2.1 Clinica case reports
5.2.2 Compliance programs
5.2.3 Health economics
5.2.4 Return on investment (ROI)
5.2.5 Healthcare quality
5.2.6 Provider incentives
5.2.7 Resource Management
5.2.8 Care Coordination
5.2.9 Others
5.3 By Delivery Mode
5.3.1 On premise
5.3.2 Web based
5.3.3 Cloud based
5.3.4 Mobile based
5.3.5 Others
5.4 By End user
5.4.1 Payers Insurance Firms
5.4.2 Providers Physicians Hospitals Community Health Centers ACO's Others
5.4.3 Employer Groups
5.4.4 Government organizations
5.5 By Geography
5.5.1 North America US Canada Mexico
5.5.2 Europe UK Germany France Spain Italy Rest of Europe
5.5.3 Asia Pacific China Japan India South Korea Rest of Asia Pacific
5.5.4 Rest of the World
6. Competitive Landscape
6.1 Mergers & Acquisitions
6.2 Agreements, Collaborations & Partnerships
6.3 New Product Launches
6.4 Recommendations to new market players
7. Company Profiles
7.1 Allscripts Healthcare Solutions
7.2 Cerner Corporation
7.3 Mckesson Corporation
7.4 Phytel
7.5 Verisk Health, Inc.
7.6 Health Catalyst
7.7 Optum
7.8 Conifer Health
7.9 Deloitte
7.10 Accenture
7.11 Wellcentive, Inc.
8. Appendix
8.1 Abbreviations
8.2 Sources
8.3 Bibliography
8.4 Disclaimer
Note: Product cover images may vary from those shown
3 of 4


4 of 4
Note: Product cover images may vary from those shown